Alon Gurfinkel
Lawyers
Filters
Vista Equity Partners investment in Reliance Industries' Jio Platforms unit
Davis Polk is advising Reliance Industries Limited and Jio Platforms Limited in connection with Vista Equity Partners’ investment of ₹11,367 crore into Jio Platforms. The…
Diageo Capital $2.5 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Diageo Capital plc of $750 million aggregate principal amount of 1.375% fixed-rate notes due 2025, …
Akeso HK$2.44 billion IPO
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…
Mitsubishi UFJ Lease & Finance $800 million senior notes offering
Davis Polk advised Mitsubishi UFJ Lease & Finance Company Limited on its Rule 144A/Regulation S offering of senior notes, which consisted of $450 million aggregate principal amount of 3…
Narragansett Electric $600 million senior notes offering
Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $600 million aggregate principal amount of 3.395% senior notes due 2030 by…
Baidu $1 billion notes offering
Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $600 million 3.075% notes due 2025 and $400 million 3.425% notes due 2030.
Baidu, Inc. is a…
Equinor $5 billion notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Equinor ASA of $1.25 billion aggregate principal amount of 2.875% fixed-rate notes…
British American Tobacco $2.4 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $900 million aggregate principal amount of 4.700% notes due 2027, $1…
Anglo American $1.5 billion notes offering
Davis Polk advised the joint bookrunners on an offering of $750 million aggregate principal amount of 5.375% senior notes due 2025 and $750 million aggregate principal amount of 5.625%…
InnoCare Pharma HK$2.24 billion IPO
Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…